AMCI Acquisition Corp. II (NASDAQ:AMCI) announced that it has added a $5 million PIPE at $10 per share to its combination with carbon capture firm LanzaTech and its shareholders approved the transaction at a special meeting February 6.
In an 8-K filed this morning, AMCI II did not divulge redemption figures, but noted that as of the meeting, “certain conditions are not yet satisfied. The Closing is expected to occur once all such conditions are satisfied or waived.” The filing also describes the additional PIPE as an effort to satisfy the deal’s $230 million, minimum cash condition.
Total PIPE funds raised in the deal are now up to $185 million and the SPAC announced an FPA effectively backstopping up to two-thirds of AMCI II’s 15,000,000 public shares yesterday.
Following close, LanzaTech’s shares and warrants are expected to trade on the Nasdaq under the symbols “LNZA” and “LNZAW,” respectively.
In addition to PIPE commitments, LanzaTech has secured a $500 million partnership with Brookfield Renewable to co-develop and build new commercial-scale production plants that will utilize the company’s technology. Following the initial investment, Brookfield disclosed that it could commit to making an additional $500 million available if sufficient projects are available at the agreed milestones.
AMCI inked its $1.8 billion deal with LanzaTech in March 2022. The Chicago-based company is developing carbon-capture plants designed to provide a number of carbon negative outputs ranging from jet fuel to consumer packaging materials.
In December, it announced it had received a £25 million ($31 million) grant from the UK Department for Transport to further develop Project DRAGON, its sustainable aviation fuel initiative.
December 2024 corporate actions continues the trend of SPAC teams seeking additional extensions beyond their third round, as they work to close their combinations with the remaining funds after redemptions. Despite this activity, both announcements and corporate actions associated with completion votes were notably few this month. Extension Votes In December, there were 26 scheduled...
At the SPAC of Dawn 2025 dawns with a reminder to SPAC teams that, as the Rolling Stones song goes, “You can’t always get what you want.” That was the message sent by Aimei Health I (NASDAQ:AFJK) shareholders as they rejected a proposal to reduce the SPAC’s monthly contribution to trust for the duration of...
An In-Depth Look at SPAC Activity Throughout the Full-Year of 2024 Below is a summary of the Full-Year 2024 SPAC market. If you’d like a pdf copy, you access the link HERE. SPACs have emerged from 2024 with a cautious optimism that feels both hard-earned and fragile. After weathering the turbulence of the past few...
The next quarter century is starting off with a set of de-SPAC shareholders newly able to realize better gains as their lock-ups expire in January than most months through 2024. Eight de-SPACs and six sponsors are to see their shares unlocked next month, and while none of these companies finished trading on December 30 in...
Maywood Acquisition Corp. (NASDAQ:MAYAU) filed to list a $75 million SPAC on the penultimate day of 2024 with a CEO making his second rodeo and a focus on serving the demand for listing opportunities and exits in Asia-Pacific. This new SPAC is not overfunding its trust and will have rights to a 1/5 share in...